Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects

NCT03393000 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

19

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision on behalf of the Sponsor.

Conditions

Glioblastoma

Interventions

DRUG: Trans Sodium Crocetinate plus SOC
OTHER: Standard of Care (SOC)

Sponsor

Diffusion Pharmaceuticals Inc